Erytech Pharma News Today

Phaxiam Therapeutics says it has notified the Nasdaq Stock Market of its intention to voluntarily delist its American Depositary Shares representing its ordinary shares, which should be effective...

Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The

04.10.2023 - PHAXIAM Receives Compliance Notice from Nasdaq Lyon (France) et Cambridge (MA, US), October 4, 2023, at 10:05 pm CEST – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), today announced that it has received confirmation from Nasdaq that it has ...

Pharmaceutical companies are investing heavily in the Acute Lymphoblastic Leukemia market, resulting in an expanding range of treatment options and a brighter outlook for patients.Wilmington, Delaware, United States, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The acute lymphoblastic leukemia market was estimated to have acquired US$ 2.2 billion in 2021. It is anticipated to register a 7.6% CAGR from 2022 to 2031 and by 2031; the market is likely to gain US$ 4.5 billion

According to Precedence Research, the global acute lymphocytic leukaemia therapeutics market size is projected to surpass around USD 8.29 billion by 2032...

ERYTECH Pharma (NASDAQ:ERYP – Get Free Report) and Scilex (NASDAQ:SCLX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends. Analyst Recommendations This is a summary of current […]

Anaesthesia Vaporizer Market | Biogen Idec, Bristol-Myers Squibb, Erytech Pharma

A genetic metabolic condition called Phenylketonuria Therapeutics Market affects how the body processes protein. Phenylalanine is an amino acid that patients with PKU are unable to effectively break down, which can result in the accumulation of harmful chemicals in the body. PKU can result in severe intellectual dis...

Dublin, Aug. 16, 2023 (GLOBE NEWSWIRE) -- The "Global Acute Lymphoblastic Leukemia Treatment Market by Types of Cell, Therapy, End-User - Cumulative...

ERYTECH Pharma S.A. (NASDAQ:ERYP – Get Free Report) dropped 1.4% on Friday . The company traded as low as $0.70 and last traded at $0.70. Approximately 984 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 93,510 shares. The stock had previously closed at $0.71. ERYTECH Pharma Price […]